After an unprecedented multi-year bull run, biotech is facing headwinds once again. Drug companies have become a target in an election year, putting pricing strategies under a microscope. Valuations have tumbled, drying up a fertile ground for IPOs. Yet biotech innovation continues apace, particularly in Boston. Gene editing has taken the scientific world by storm, and may soon reach human clinical testing. New ways of harnessing the immune system to battle cancer are being unlocked. Investments in neuroscience, long a drug development minefield, have picked up. And local venture firms are armed with new funds to spend on startups.

What ideas are innovators focusing on? What hurdles do they have to cross? And how, in a more challenging environment, can those ideas best move forward?

Join Xconomy as we bring together a group of Boston biotech’s top entrepreneurs, investors, and leaders to explore these, and other topics on the local life sciences horizon.

Confirmed Speakers
Chris Viehbacher, Executive Chairman, Boston Pharmaceuticals; Managing Partner, Gurnet Point Capital
Phillip A. Sharp, Nobel Laureate; Institute Professor, MIT
Nessan Bermingham, Founder & CEO, Intellia
Bruce Booth, Partner, Atlas Venture
Deborah Dunsire, CEO, Forum Pharmaceuticals
Gregory Verdine, Founder & CSO, Warp Drive Bio; Professor, Harvard University
Al Sandrock, EVP & Chief Medical Officer, Biogen
Peter Hecht, CEO, Ironwood Pharmaceuticals
Jens Eckstein, President, SR One
Peter Kolchinsky, Founder & Managing Director, RA Capital
Nir Hacohen, Co-founder, Neon Therapeutics; Director, MGH Center for Immunotherapy
Cary Pfeffer, Interim CEO, Neon Therapeutics; Partner, Third Rock Ventures
Daphne Zohar, CEO, Puretech Health
Robert Urban, Head, Johnson & Johnson Innovation, Boston

Twitter
@Xconomy
#xconbio

Schedule
Registration & Networking: 12:30 – 1:30 pm
Program: 1:30 – 5:30 pm
Networking Reception: 5:30 – 6:30 pm

Ticket Information
Tickets are transferable but not refundable.
To inquire about press registration, email events@xconomy.com.

*Speakers and program schedule are subject to change.